Drreddys Laboratories reported $23.5B in Cost of Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Ani Pharmaceuticals ANIP:US $ 24.41M 2.1M
Aphria Inc APH:CN C$ 160.92M 13.78M
Aurora Cannabis Inc ACB:CN 46M 69.67M
Bayer BAYN:GR € 3887M 659M
Canopy Growth Corp WEED:CN C$ 202.51M 93.54M
Catalent CTLT:US $ 701M 47.9M
Cipla CIPLA:IN 21.37B 678.5M
Corcept Therapeutics CORT:US $ 1.27M 0.11M
Endo International Ordinary Shares ENDP:US $ 297.12M 16.31M
GlaxoSmithKline GSK:LN 2822M 303M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Hikma Pharmaceutical HIK:LN 600M 2M
Horizon Pharma HZNP:US $ 251.64M 50.64M
JAZZ PHA JAZZ:US $ 145.22M 26.03M
Lannett LCI:US $ 85M 1.65M
Lonza Group LONN:SW 1.5B 690M
Novartis NOVN:VX SF 3848M 94M
Pacira Pharmaceuticals PCRX:US $ 34.65M 0.6M
Phibro Animal Health PAHC:US $ 149.99M 0.46M
Prestige Brands PBH:US $ 118.51M 8.34M
Richter Gedeon RICHT:HB 71.8B 4.12B
Sun Pharmaceuticals SUNP:IN IR 25218.6M 1275.7M
Supernus Pharmaceuticals SUPN:US $ 18.08M 6.94M
Teva Pharmaceutical TEVA:IT 1.99B 2M